Global 3D Cell Culture and 3D Bioprinting Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global 3D Cell Culture and 3D Bioprinting Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
3D cell culture refers to a technique in cell biology and tissue engineering where cells are grown or cultured in a three-dimensional environment that better mimics the natural conditions found in living organisms compared to traditional two-dimensional (2D) cell cultures.
3D bioprinting is an advanced additive manufacturing technology used in the field of regenerative medicine and tissue engineering. It involves the precise layer-by-layer deposition of biological materials (such as cells, growth factors, and biomaterials) to create three-dimensional structures that mimic human tissues and organs.
Global 3D Cell Culture and 3D Bioprinting market is projected to reach US$ 4690.9 million in 2033, increasing from US$ 2060.8 million in 2022, with the CAGR of 12.8% during the period of 2023 to 2033. Demand from Cancer and Stem Cell Research and Drug Discovery and Toxicology Testing are the major drivers for the industry.
Improved methods for growing and maintaining organoids, which are three-dimensional, miniature organs that closely mimic the structure and function of real organs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global 3D Cell Culture and 3D Bioprinting market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
3D Biotek LLC
Aspect Biosystems Ltd.
CELLINK
CN Bio Innovations Ltd.
Corning Incorporated
CYFUSE BIOMEDICAL K.K.
GeSiM
InSphero
Lonza
Merck KGaA
Organovo Holdings Inc.
REPROCELL Inc.
Thermo Fisher Scientific Inc.
ENVISIONTEC
Segment by Type
3D Cell Culture
3D Bioprinting
Cancer and Stem Cell Research
Drug Discovery and Toxicology Testing
Tissue Engineering and Regenerative Medicine
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the 3D Cell Culture and 3D Bioprinting market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, 3D Cell Culture and 3D Bioprinting introduction, etc. 3D Cell Culture and 3D Bioprinting Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of 3D Cell Culture and 3D Bioprinting market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
3D bioprinting is an advanced additive manufacturing technology used in the field of regenerative medicine and tissue engineering. It involves the precise layer-by-layer deposition of biological materials (such as cells, growth factors, and biomaterials) to create three-dimensional structures that mimic human tissues and organs.
Global 3D Cell Culture and 3D Bioprinting market is projected to reach US$ 4690.9 million in 2033, increasing from US$ 2060.8 million in 2022, with the CAGR of 12.8% during the period of 2023 to 2033. Demand from Cancer and Stem Cell Research and Drug Discovery and Toxicology Testing are the major drivers for the industry.
Improved methods for growing and maintaining organoids, which are three-dimensional, miniature organs that closely mimic the structure and function of real organs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global 3D Cell Culture and 3D Bioprinting market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
3D Biotek LLC
Aspect Biosystems Ltd.
CELLINK
CN Bio Innovations Ltd.
Corning Incorporated
CYFUSE BIOMEDICAL K.K.
GeSiM
InSphero
Lonza
Merck KGaA
Organovo Holdings Inc.
REPROCELL Inc.
Thermo Fisher Scientific Inc.
ENVISIONTEC
Segment by Type
3D Cell Culture
3D Bioprinting
Segment by Application
Cancer and Stem Cell Research
Drug Discovery and Toxicology Testing
Tissue Engineering and Regenerative Medicine
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the 3D Cell Culture and 3D Bioprinting market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, 3D Cell Culture and 3D Bioprinting introduction, etc. 3D Cell Culture and 3D Bioprinting Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of 3D Cell Culture and 3D Bioprinting market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.